Amaia Latasa Arrazubi Institutions of which they are part Medium Grade Technician Academic Research Organisation (ARO) Clinical Core Facilities External Strategy Directorate Vall Hebron Institut de Recerca Email Amaia Latasa Arrazubi Email Institutions of which they are part Medium Grade Technician Academic Research Organisation (ARO) Clinical Core Facilities External Strategy Directorate Vall Hebron Institut de Recerca
Projects Plataforma de soporte para la Investigación Clínica IP: Inmaculada Fuentes Camps Collaborators: Antonio Moreno Galdó, Rafael Simó Canonge, Tamara Del Rio Higueras, Ariadna Martín Balcells, Mª Eulàlia Molinas Guilera, Laura Cascales Bolaño, Plataforma de soporte para la Investigación Clínica, Olga Sánchez- Maroto Carrizo, Maria Soraya Badia Ventura, Angelica Valderrama Rodríguez, Amaia Latasa Arrazubi, Joan Genescà Ferrer, Gemma Vona Giralt, Paula Isabel Roldan Caballero Funding agency: Instituto de Salud Carlos III Funding: 274920 Reference: PT23/00062 Duration: 01/01/2024 - 31/12/2026 RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2 IP: Pere Soler Palacín Collaborators: Miriam Gonzalez Amores, RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2, Tamara Del Rio Higueras, Ariadna Martín Balcells, Amaia Latasa Arrazubi, RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2, Noemí Giménez Sanz, Olga Sánchez- Maroto Carrizo, Maria Soraya Badia Ventura Funding agency: EUROPEAN COMMISSION Funding: 475000 Reference: RBDCOV_HE-HLTH-CORONA2021 Duration: 01/12/2021 - 31/05/2024 Immune profiling to guide host-directed interventions to cure HBV infections IP: Maria Buti Ferret Collaborators: Tamara Del Rio Higueras, Mª Eulàlia Molinas Guilera, Amaia Latasa Arrazubi, Judit Vico Romero, Alejandro López Targa, Maria del Mar Riveiro Barciela Funding agency: EUROPEAN COMMISSION Funding: 211443.8 Reference: IP-CURE-B_H2020SC1BHC2019 Duration: 01/01/2020 - 31/12/2024 LIVERHOPE: SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS IP: LIVERHOPE: SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS Collaborators: Ester Palacio Gutierrez, Mª Eulàlia Molinas Guilera, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi, Joan Genescà Ferrer, LIVERHOPE: SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS Funding agency: EUROPEAN COMMISSION Funding: 409557 Reference: LIVERHOPE_H2020RTD2016 Duration: 01/01/2017 - 28/02/2023 Pagination Current page 1 Page 2 Next page › Last page »